New Research Offers Fresh Insights Into Early Cancer Detection via MicroRNA Blood Panels
A multi-centre clinical trial spanning 12,000 participants shows an 89% sensitivity rate in pinpointing stage-1 malignancies through specialized circulating microRNA signatures.






